A carregar...
KCNQ3 is the principal target of retigabine in CA1 and subicular excitatory neurons
Retigabine is a first-in-class potassium channel opener approved for patients with epilepsy. Unfortunately, several side effects have limited its use in clinical practice, overshadowing its beneficial effects. Multiple studies have shown that retigabine acts by enhancing the activity of members of t...
Na minha lista:
| Publicado no: | J Neurophysiol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Physiological Society
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8282224/ https://ncbi.nlm.nih.gov/pubmed/33729829 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/jn.00564.2020 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|